Medical Device Cost Guides (2026)
Complete pricing breakdowns for 62 medical devices. New, used, financing, and total ownership costs.
Last updated: 2026-04-09
Medical device pricing is one of the least transparent areas in healthcare capital equipment. Manufacturer list prices are starting points, not transaction prices. Used market values move weekly. Total cost of ownership including consumables, maintenance, training, and software updates is rarely documented before purchase. Financing terms vary widely across lenders. Section 179 tax treatment dramatically changes after-tax cost.
Device Pulse publishes a complete cost guide for every device we cover. Each guide breaks down new pricing (with realistic transaction discounts), used and refurbished pricing from secondary market data, monthly financing payments at typical equipment loan rates, total cost of ownership over five years, Section 179 tax savings, per-treatment economics, resale value retention, and what to negotiate beyond the headline discount.
All pricing is sourced from authorized dealers, DOTmed, secondary market platforms, and direct practice surveys. We don't accept manufacturer sponsorship for any cost guide. Use these guides to validate vendor quotes, negotiate stronger deals, and avoid the most common buying mistakes physicians make when purchasing capital equipment.
What's in a Device Pulse cost guide
Every cost guide follows the same structure to make comparison easy across devices:
- New pricing. Current authorized dealer pricing with realistic transaction discounts (most deals close 10-20% below list).
- Used and refurbished pricing. Secondary market data from DOTmed, MedPro Lasers, Rock Bottom Lasers, and direct practice sales.
- Monthly financing payments. Estimated monthly payments at typical equipment loan rates (8% APR over 60 months) for both new and used purchases.
- Total cost of ownership (5-year). Capital cost plus consumables, maintenance, training, and incidental costs over the typical equipment life.
- Section 179 tax savings. First-year tax deduction analysis at typical 35% effective tax rates.
- Per-treatment economics. Revenue per session, gross margin per treatment, and break-even volume analysis.
- Resale value. Expected secondary market value at 1, 3, and 5 years.
- Negotiation tactics. Discount benchmarks, optimal timing, and items to negotiate beyond price.
Why pricing transparency matters for physician buyers
The medical device industry has historically operated on opaque pricing because that opacity benefits manufacturers. Sales reps can quote different prices to different practices based on negotiating power, perceived buying power, urgency, and dozens of other factors. Without independent pricing data, physician buyers have no way to know whether they're getting a fair deal or paying 20% more than the practice down the street paid for the same device last quarter.
The information asymmetry is even worse for first-time category buyers. A practice buying its first body contouring platform doesn't know what realistic transaction prices look like, what's negotiable, what to ask for in a bundle, or when to walk away from a bad deal. The result: first-time buyers consistently overpay relative to experienced category buyers who have learned the negotiation rhythms.
Device Pulse cost guides exist to close that information gap. Every guide is built on real transaction data from authorized dealers, secondary market platforms, and direct practice surveys. We update the data quarterly and flag significant movements through our weekly newsletter. The goal is to give first-time category buyers the same pricing intelligence that experienced buyers develop over years of negotiating with manufacturers.
The economic environment in 2026 makes this even more important. With several major manufacturers under financial pressure and capital equipment buying slowing across the industry, transaction prices have become more flexible than they've been in years. Buyers who walk into negotiations armed with current pricing data and clean ROI projections capture 10 to 20 percent better deals than buyers who rely on the manufacturer's first quote.
Reading a manufacturer quote correctly
Every manufacturer quote contains line items beyond the device price itself. Reading the full quote correctly is the difference between a fair deal and overpaying by tens of thousands. The line items to scrutinize:
Equipment line. The headline price. Should reflect 10-20% off list for single devices or 20-30% off for bundles. If the quote shows full list price, the rep is anchoring high. Push back immediately.
Training fees. Often $2,000-$10,000 per provider. Should be included for at least two providers in any deal. If charged separately for each provider, negotiate them down or get them included.
Installation and delivery. Sometimes a separate $500-$3,000 line item. Should usually be included in the deal, especially for major purchases.
Software licensing. Some manufacturers charge ongoing software fees separate from the equipment. Verify whether software updates are included in the warranty period.
Consumable starter package. Should cover 30-90 days of typical practice use. If not included, push for inclusion or negotiate the consumable price.
Warranty. Standard warranty is usually 12 months. Push for 24-36 months. The extended coverage saves $5,000-$15,000 in service costs over the warranty period.
Service contract. Usually offered separately at 5-10% of equipment cost per year. Compare against third-party biomedical service options before signing.
Get every line item in writing. Verbal commitments from sales reps disappear when the deal moves to legal and operations. The contract is the only thing that matters once the rep moves on.